Oxford Financial Group LTD. LLC acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,066 shares of the conglomerate’s stock, valued at approximately $965,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. D L Carlson Investment Group Inc. bought a new position in Danaher during the 2nd quarter worth approximately $6,800,000. Portfolio Design Labs LLC bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $992,000. Reliant Investment Partners LLC bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $369,000. Ninepoint Partners LP acquired a new stake in shares of Danaher during the 2nd quarter valued at approximately $1,542,000. Finally, Advisors Capital Management LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at approximately $1,877,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Trading Up 2.2%
Danaher stock opened at $216.14 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $151.94 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 2.63 and a beta of 0.78. The firm has a 50-day moving average price of $195.01 and a two-hundred day moving average price of $192.43.
Analysts Set New Price Targets
A number of equities analysts have commented on DHR shares. Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, Guggenheim lowered their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $228.91.
Get Our Latest Research Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
